Global Supply Chain ציבורי
[search 0]
עוד
Download the App!
show episodes
 
Global Supply Chain Group (globalscgroup.com) Strategy Consulting and Services specialise in global supply chains provide a straight from the coal face look at what is really happening in supply chains today. With 21 years of running the strategy consulting company called Global Supply Chain Group - the principal, Vivek Sood has been called "Mr Supply Chain" by his CEO clients of large global multi-national companies. His blogs and podcasts provide a fresh perspective without any hyperbole o ...
  continue reading
 
Loading …
show series
 
Cell & Gene Therapies hold incredible potential for improving – if not saving – human lives. These CGT’s have been called “living drugs” and can heal diseased organs and – we hope – fight diseases that currently have no cure. Because of these incredible possibilities, related research and development is growing exponentially around the globe, with …
  continue reading
 
In Part 2 of our conversation, Scott Ohanesian, QuickSTAT’s senior VP of Commercial Operations, and Mike Sweeney, QuickSTAT's Global Head of Strategy for CGT and Direct to Patient Products discuss the various challenges around the logistics of Cell & Gene Therapy – what to look out for and the importance of being prepared. We also look forward and …
  continue reading
 
Medical care and scientific research offer some of the most challenging – and developing – areas for global supply chain logistics. And few are more significant– in terms of potential for improving human life and logistics precision required – than Cell & Gene Therapy or CGT. These CGT “medical miracles” bring logistics opportunities and challenges…
  continue reading
 
In Part 2, Mike Sweeney, QuickSTAT’s Global Head of Strategy for CGT and Direct to Patient products, offers specific supply chain design ideas and tactics to establish processes and overcome potential logistics roadblocks. He breaks down extraordinary case studies, and gives his views on what’s next – particularly around regulation.…
  continue reading
 
Critically ill patients increasingly can participate in life saving and life changing cell & gene therapy clinical trials without having to leave their homes with the Direct- to -Patient and Direct- from -Patient model. So how do you set up these supply chains? How do you mitigate risk? And how do you ensure they’re resilient? Mike Sweeney, QuickST…
  continue reading
 
Loading …

מדריך עזר מהיר